Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CLA-mix refers to a mixture of conjugated linoleic acid (CLA) isomers, most commonly the cis-9, trans-11 and trans-10, cis-12 forms. CLA is a naturally occurring polyunsaturated omega-6 fatty acid found in meat and dairy products from ruminant animals. Commercially available CLA supplements are typically produced by the alkaline isomerization of linoleic acid-rich oils (such as sunflower oil) and contain an equimolar or variable mixture of these two main isomers along with smaller amounts of other positional/geometric isomers[6]. CLA has been marketed primarily for weight management and body fat reduction. Some studies suggest it may modestly decrease body fat in adults and children but does not consistently reduce overall body weight or BMI[1][2][3]. Other purported uses include improving blood pressure when combined with antihypertensive drugs like ramipril[1], cancer prevention (with mixed evidence), cardiovascular health, immune modulation, and effects on bone health in certain populations[4][5][6]. Mechanistically, different CLA isomers have distinct biological activities. The antiobesity effect appears more attributable to the trans-10, cis-12 form; anticarcinogenic effects are linked to the cis-9, trans-11 form[5][6]. Proposed mechanisms include reduced prostaglandin synthesis (notably PGE2), inhibition of stearoyl-CoA desaturase activity (affecting lipid metabolism), decreased insulin-like growth factor-II secretion at multiple levels, increased apoptosis via caspase activation in some tissues, suppression of fatty acid synthesis in cancer cells, inhibition of matrix metalloproteinase 9 reducing tumor invasion/angiogenesis in some cancers[5]. Despite its popularity as a supplement for weight loss or bodybuilding purposes due to its potential to reduce body fat while preserving muscle mass[9], clinical evidence remains inconsistent regarding efficacy for any indication. Side effects can include gastrointestinal upset (nausea/diarrhea/stomachache/bloating), headache/fatigue/skin rash; higher doses may increase risk for liver fat accumulation or insulin resistance especially with long-term use above 3–4 grams per day[7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CLA-mix.